ArticleFrontiers in pharmacology2026
Pharmacological safety and real-world efficacy of the potassium-competitive acid blocker fexuprazan in cardiovascular patients receiving antithrombotic therapy: a prospective cohort study (FEXGARD).
You Mi Hwang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.